This is a preview of subscription content, log in via an institution to check access.
Reference
Stevens ER, et al. Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population. Clinical Infectious Diseases : 11 Aug 2019. Available from: URL: http://doi.org/10.1093/cid/ciz726
Rights and permissions
About this article
Cite this article
Finding cost-effective options to reduce HCV in injection drug users. PharmacoEcon Outcomes News 835, 14 (2019). https://doi.org/10.1007/s40274-019-6151-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6151-8